Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Actelion Ltd
Actelion recruits for studies of sickle cell disease, pulmonary hypertension
May 8th, 2006
Actelion Ltd announced that it is recruiting for two new clinical trials in patients with pulmonary hypertension (PH) secondary to sickle cell disease (SCD). The investigators are collecting data on key measures of clinical success such as pulmonary vascular resistance, exercise capacity, clinical outcomes, which include prevention of hospitalization, decreased number of sickle cell crises, death and other important clinical assessments, and safety. Both trials are currently registering eligible patients that are 12 years of age and older. Interested patients and physicians can contact Actelion Pharmaceuticals, Inc. Investigators...
Source: Biotech Week (2006-05-08)
|
